Reviews
Description
1. Histopathology and grading of breast cancer.- 2. Multicentric/multifocal breast cancer: overview, biology and therapy.- 3. The immune system in breast cancer initiation and progression: role of epithelial to mesenchymal transition.- 4. Remodeling of the extracellular matrix: implications for cancer.- 5. Biology and treatment of basal-like breast cancer.- 6. Re-excision after lumpectomy for breast cancer.- 7. Novel anti-angiogenic therapies using naturally-occurring and synthetic drugs to combat progestin-dependent breast cancer.- 8. New insights on estrogen receptor actions in hormone-responsive breast cancer cells by interaction proteomics.- 9. Reprogramming breast cancer cells with embryonic microenvironments: insights from nodal signaling.- 10. Metastatic determinants: breast tumour cells in circulation.- 11. Breast cancer epigenetics: biomarkers and therapeutic potential.- 12. The impact of centrosome abnormalities on breast cancer development and progression with a focus on targeting centrosomes for breast cancer therapy.- 13. A New Perspective on Cyclin D1: beyond cell cycle regulation.- 14. Gene signatures of inflammatory breast cancer: epithelial plasticity and a cancer stem cell phenotype.- 15. An integrated human mammary epithelial cell culture system for studying carcinogenesis and aging.- 16. New breast cancer treatment considerations - a brief review of the use of genetically modified (attenuated) bacteria as therapy for advanced and metastatic breast cancer.
EXTRA 10 % discount with code: EXTRA
The promotion ends in 21d.23:07:46
The discount code is valid when purchasing from 10 €. Discounts do not stack.
1. Histopathology and grading of breast cancer.- 2. Multicentric/multifocal breast cancer: overview, biology and therapy.- 3. The immune system in breast cancer initiation and progression: role of epithelial to mesenchymal transition.- 4. Remodeling of the extracellular matrix: implications for cancer.- 5. Biology and treatment of basal-like breast cancer.- 6. Re-excision after lumpectomy for breast cancer.- 7. Novel anti-angiogenic therapies using naturally-occurring and synthetic drugs to combat progestin-dependent breast cancer.- 8. New insights on estrogen receptor actions in hormone-responsive breast cancer cells by interaction proteomics.- 9. Reprogramming breast cancer cells with embryonic microenvironments: insights from nodal signaling.- 10. Metastatic determinants: breast tumour cells in circulation.- 11. Breast cancer epigenetics: biomarkers and therapeutic potential.- 12. The impact of centrosome abnormalities on breast cancer development and progression with a focus on targeting centrosomes for breast cancer therapy.- 13. A New Perspective on Cyclin D1: beyond cell cycle regulation.- 14. Gene signatures of inflammatory breast cancer: epithelial plasticity and a cancer stem cell phenotype.- 15. An integrated human mammary epithelial cell culture system for studying carcinogenesis and aging.- 16. New breast cancer treatment considerations - a brief review of the use of genetically modified (attenuated) bacteria as therapy for advanced and metastatic breast cancer.
Reviews